India’s defence sector stocks have witnessed a brutal correction. Hindustan Aeronautics (HAL), Bharat Electronics (BEL), and Bharat Dynamics (BDL) have each fallen 35-45% from their July 2024 peaks, wiping out over Rs 2 lakh crore in combined market capitalization. For investors who missed the original rally, does this correction offer a second chance?
Why Did Defence Stocks Crash?
The correction wasn’t driven by deteriorating fundamentals but by three factors:
- Extreme Valuation: At peak, HAL traded at 45x PE, BEL at 55x, and BDL at 80x — pricing in 5+ years of growth. Any sector trading at such premiums is vulnerable to de-rating
- Broad Market Selloff: FII selling and small/mid-cap weakness dragged down all high-PE stocks
- Order Book Concerns: Some investors worried about the pace of new order announcements slowing after the election-year burst
Fundamentals: Still Rock Solid
The underlying investment thesis hasn’t changed:
- India’s defence budget for FY27 is Rs 6.82 lakh crore (+9.5% YoY), with capital expenditure at Rs 1.8 lakh crore
- HAL’s order book: Rs 1.2 lakh crore (4x trailing revenue). Tejas Mk2 program alone worth Rs 67,000 crore. LCA naval variant and AMCA development provide multi-decade visibility
- BEL’s order book: Rs 76,000 crore (4.5x revenue). Growing non-defence business (smart cities, metro systems) now at 24% of revenue
- Defence exports crossed Rs 23,600 crore in FY26, up from Rs 1,500 crore five years ago. India targets Rs 50,000 crore by FY29
Current Valuations
HAL at Rs 3,450 trades at 28x FY27E PE — still above the sector average but far more reasonable than 45x. Earnings are growing at 20%+ CAGR, supporting the premium. BEL at Rs 255 (32x PE) and BDL at Rs 1,080 (38x PE) have also become more palatable.
Investment Strategy
HAL: Best risk-reward in the sector. Start accumulating at current levels with a 2-year target of Rs 4,500. It’s India’s only large-cap pure defence play with Tejas production scaling up.
BEL: Buy in tranches between Rs 240-260. Diversified product portfolio reduces concentration risk. Target: Rs 340.
BDL: High-beta play, wait for Rs 950-1,000 for better margin of safety.